David Young - Pres. Research & Development, Director at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. Research & Development, Director
Stock Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David Young - trading volume in the past year for Processa Pharmaceuticals, Inc.

Holdings reported by David Young for Processa Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 80.9K $138K $1.71 Jul 10, 2024 Direct
Common Stock 31K $53K $1.71 Apr 5, 2024 By Young-Plaisance Revocable Trust
Restricted Stock Units 25.2K $43K $1.71 Jun 28, 2024 Direct Common Stock
Common Stock 18.5K $31.7K $1.71 Apr 5, 2024 By CorLyst, LLC
Common Stock 10.8K $18.4K $1.71 Apr 5, 2024 By Family Entities

Transactions reported by David Young for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.